Biomarker Detection
Antibodies, ELISA kits, proteins and controls for pancreatic cancer markers.
Explore research-use products for pancreatic ductal adenocarcinoma, pancreas tumor biology, KRAS signaling, TP53, CDKN2A, SMAD4, CA19-9, BRCA/PALB2 DNA repair, tumor stroma, CAF markers, immune suppression, hypoxia, metabolism, organoid models, spheroid workflows and experimental drug-response assays.
Build pancreas tumor research workflows using antibodies, ELISA kits, recombinant proteins, molecular biology tools, cell culture reagents and functional assay systems.
Primary antibodies for CA19-9, MUC1, CEACAM5, EPCAM, KRAS, TP53, SMAD4, Ki-67, αSMA, FAP, PD-L1, CD8, CD68, VEGF and stromal markers.
View antibodiesKits and assays for pancreatic tumor biomarkers, cytokines, chemokines, angiogenesis markers, stromal factors, inflammation and immune mediators.
View ELISA kitsRecombinant proteins, calibrators and standards for assay development, pathway stimulation, antibody validation and experimental controls.
View proteinsMolecular tools for KRAS, TP53, CDKN2A, SMAD4, BRCA/PALB2, EMT, hypoxia, immune signaling, DNA damage response and subtype profiling.
View molecular toolsMedia, matrices, supplements, transfection reagents and 3D culture tools for pancreatic tumor cells, organoids, spheroids and stromal co-culture models.
View culture toolsATP, cytotoxicity, apoptosis, proliferation, invasion, migration, DNA damage, oxidative stress, hypoxia and spheroid-response assay systems.
View assay toolsPancreatic cancer research often studies oncogenic signaling, tumor suppressor loss, carbohydrate antigens, epithelial markers, stromal activation, immune infiltration, hypoxia and drug resistance.
KRAS is a central PDAC research target connected with growth signaling, metabolism, immune modulation and treatment resistance.
CA19-9 is widely studied in pancreatic cancer biomarker research, assay development and monitoring-context workflows.
SMAD4 is frequently studied in pancreatic cancer progression, invasion, stromal crosstalk and tumor suppressor biology.
αSMA and FAP are used to study cancer-associated fibroblasts, desmoplasia and pancreatic tumor microenvironment biology.
Choose a workflow and get product groups matched to pancreatic tumor research needs.
Recommended product groups: primary antibodies, secondary antibodies, FFPE-compatible markers, antigen retrieval reagents, CA19-9, MUC1, EPCAM, KRAS, TP53, SMAD4, Ki-67, αSMA, FAP, CD8, CD68, PD-L1 and VEGF.
Browse tissue research productsUse pancreas tumor research products across biomarker discovery, assay validation, molecular pathway analysis, microenvironment studies and drug-response models.
Study KRAS, TP53, CDKN2A, SMAD4, CA19-9, invasion, stroma and progression.
Analyze MAPK/ERK, PI3K/AKT, metabolism, survival signaling and resistance mechanisms.
Study αSMA, FAP, collagen, hyaluronan, extracellular matrix and desmoplastic response.
Profile CD8, CD68, PD-L1, macrophages, myeloid cells, cytokines and immune exclusion.
Build 3D models for metabolism, hypoxia, matrix interaction and drug-response testing.
Measure viability, apoptosis, ATP, cytotoxicity, DNA damage, invasion and resistance.
Product selection should match the biological target, model system, sample type, assay format and validation requirements.
Examples: KRAS signaling, CA19-9 detection, SMAD4 loss, CAF activation, immune profiling or drug response.
Review compatibility with FFPE tissue, frozen tissue, serum, plasma, lysates, 2D cells, spheroids or organoids.
Confirm suitability for IHC, WB, IF, ELISA, qPCR, flow cytometry, cell culture or functional assays.
Include positive controls, negative controls, calibrators, reference lysates and reproducibility checks.
Explore research-use tools for pancreatic tumor biomarkers, PDAC biology, KRAS signaling, stromal microenvironment, organoids, spheroids, immune profiling and experimental drug-response workflows.
Clear answers to common product-selection and pancreatic tumor workflow questions.
Pancreatic cancer research products are laboratory-use reagents and assay tools used to study pancreatic tumor biology, PDAC biomarkers, KRAS signaling, tumor stroma, immune microenvironment, organoids, spheroids and drug response.
Frequently studied biomarkers include KRAS, TP53, CDKN2A, SMAD4, CA19-9, MUC1, EPCAM, Ki-67, αSMA, FAP, CD8, CD68, PD-L1, VEGF, BRCA1 and BRCA2.
Tissue-based studies commonly use primary antibodies, secondary antibodies, IHC reagents, FFPE-compatible controls, epithelial markers, stromal markers, proliferation markers and immune markers.
No. Products described on this page are presented for research use only unless an individual product page clearly states otherwise.
Authoritative sources supporting pancreatic cancer biology, biomarkers and research context.